Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial (Q33988701)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q7342606)
(P304) 2557-2564
(P407) (Q1860)
(P433) 23
(P478) 302
(P577) Tuesday, December 1, 2009
(P921) (Q11081)
(P1433) (Q1470970)
(P1476) "Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial" (language: en)
(P2093) Lon S Schneider
David A Amato
Andrew P Beelen
Gordon Wilcock
Edward A Swabb
Kenton H Zavitz
Tarenflurbil Phase 3 Study Group
(P2860) (Q35876532)
(Q34598450)
(Q37182828)
(Q34727482)
(Q33291589)
(Q34374693)
(Q24793976)
(Q24679444)
(Q28131806)
(Q41749781)
(Q28252389)
(Q34433716)
(Q41471895)
(Q29616280)
(Q53199281)
(Q27860795)
(Q53197509)
(Q29547160)
(Q25938989)
(Q46616657)
(Q44557611)
(Q43918834)
(Q43793656)
(Q45084030)
(Q53187091)
(Q67590396)